Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2003, 49, 69-73

https://doi.org/10.14712/fb2003049020069

Adjuvant Autologous Tumour Cell-Lysate Vaccine versus No Adjuvant Treatment in Patients with M0 Renal Cell Carcinoma after Radical Nephrectomy: 3-Year Interim Analysis of a German Multicentre Phase-III Trial

Christian Doehn1, A. Richter2, W. Lehmacher3, D. Jocham1

1Department of Urology, University of Lübeck Medical School, Lübeck, Germany
2Department of Urology, St. Georg Hospital Leipzig, Leipzig, Germany
3Institute for Medical Statistics, University of Cologne Medical School, Cologne, Germany

Received January 2003
Accepted February 2003

References

1. Basting, R., Corvin, S., Handel, D., Hinke, A., Schmidt, D. (1999) Adjuvant immunotherapy in renal cell carcinoma - comparison of interferon alpha treatment with untreated control. Anticancer Res. 19, 1545-1548.
2. Boon, T., Cerottini, J. C., Van den Eynde, B., Van der Bruggen, P., Van Pel, A. (1994) Tumor antigens recognized by T lymphocytes. Rev. Immunol. Ann. 12, 337-365. <https://doi.org/10.1146/annurev.iy.12.040194.002005>
3. Dal Bianco, M., Arbitani, W., Bassi, P. F., Pescatori, E., Pagano, F. (1988) Prognostic factors in renal cell carcinoma. Eur. Urol. 115, 73-76. <https://doi.org/10.1159/000473400>
4. Dillman, R. O., Nayak, S. K., Beutel, L. (1993) Establishing in vitro cultures of autologous tumor cells for use in active specific immunotherapy. J. Immunother. 14, 65-69. <https://doi.org/10.1097/00002371-199307000-00009>
5. Dinney, C. P., Awad, S. A., Gajewski, J. B., Belitsky, P., Lannon, S. G., Mack, F. G., Millard, O. H. (1992) Analysis of imaging modalities, staging systems, and prognostic indicators for renal cell carcinoma. Urology 39, 122-129. <https://doi.org/10.1016/0090-4295(92)90267-Z>
6. Figlin, R. A. (1999) Renal cell carcinoma: management of advanced disease. J. Urol. 161, 381-387. <https://doi.org/10.1016/S0022-5347(01)61897-4>
7. Finney, R. (1973) The value of radiotherapy in the treatment of hypernephroma - a clinical trial. Br. J. Urol. 45, 258-269. <https://doi.org/10.1111/j.1464-410X.1973.tb12152.x>
8. Fischer, C. C., Wächter, W. C., Fuentecilla Perez, E., Miller, J., Weidner, W., Dudeck, J. (1997) Urologic tumors in Germany. Urologe A 36, 143-150. <https://doi.org/10.1007/s001200050080>
9. Galligioni, E., Quaia, M., Merlo, A., Carbone, A., Spada, A., Favaro, D., Santarosa, M., Sacco, C., Talamini, R. (1996) Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guerin: five-year results of a prospective randomized study. Cancer 77, 2560-2566. <https://doi.org/10.1002/(SICI)1097-0142(19960615)77:12<2560::AID-CNCR20>3.0.CO;2-P>
10. Gansbacher, B., Zeier, K., Daniels, B., Cronin, K., Bennerji, R., Gilboa, E. (1990) Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172, 1217-1224. <https://doi.org/10.1084/jem.172.4.1217>
11. Giuliani, L., Gilberti, C., Martorana, G., Rovida, S. (1990) Radical extensive surgery for renal cell carcinoma: longterm results and prognostic factors. J. Urol. 143, 468-474. <https://doi.org/10.1016/S0022-5347(17)39992-5>
12. Guinan, P. D., Vogelzang, N. J., Fremgen, A. M., Chmiel, J. S., Sylvester, J. L., Sener, S. F., Imperato, J. P. (1995) Renal cell carcinoma: tumor size, stage and survival. J. Urol. 153, 901-903. <https://doi.org/10.1016/S0022-5347(01)67599-2>
13. Goldschmidt, A. J. W., Hockertz, S. W., Repmann, R., Richter, A., Ulbrich, C., Groflmann, A. (1998) Adjuvant therapy of renal cell carcinoma (RCC) with a pure-celllysate autologous tumor vaccine (aTm): a 3-year-followup-analysis. Proc. Am. Ass. Cancer Res. 39, 367.
14. Hermanek, P., Schrott, K. M. (1990) Evaluation of the new tumor, nodes and metastases classification of renal carcinoma. J. Urol. 144, 238-242. <https://doi.org/10.1016/S0022-5347(17)39420-X>
15. Jeon, S. H., Chang, S. G., Kim, J. I. (1999) The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in factors in pT3N0M0 renal cell carcinoma. Anticancer Res. 19, 5593-5597.
16. Kjaer, M., Frederiksen, P. L., Engelholm, S. A. (1987) Postoperative radiotherapy in stage II and III renal adenocarcinoma. A randomized trial by the Copenhagen renal cancer study group. Int. J. Radiat. Oncol. Biol. Physiol. 13, 665-672. <https://doi.org/10.1016/0360-3016(87)90283-5>
17. Kriegmair, M., Oberneder, R. (1995) Tumor cell vaccination for treatment of renal cell carcinoma. Urologe A 34, 204-207.
18. Levy, D. A., Slaton, J. W., Swanson, D. A., Dinney, C. P. (1998) Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J. Urol. 159, 1163-1167. <https://doi.org/10.1016/S0022-5347(01)63541-9>
19. Makarewicz, R., Zarzycka, M., Kulinska, G., Windorbska, W. (1998) The value of postoperative radiotherapy in advanced renal cell cancer. Neoplasma 45, 380-383.
20. McNichols, D. W., Segura, J. W., DeWeerd, J. H. (1981) Renal cell carcinoma: long-term survival and late recurrence. J. Urol. 126, 17-23. <https://doi.org/10.1016/S0022-5347(17)54359-1>
21. Migliari, R., Muscas, G., Solinas, A., Melis, M., Ionta, M. T., Massidda, B., Usai, E. (1995) Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT23N0M0 renal cell carcinoma? J. Chemother. 7, 240-245. <https://doi.org/10.1179/joc.1995.7.3.240>
22. Motzer, R. J., Bander, N. H., Nanus, D. M. (1996) Renal-cell carcinoma. New Engl. J. Med. 335, 865-875. <https://doi.org/10.1056/NEJM199609193351207>
23. Motzer, R. J., Russo, P. (2000) Systemic therapy for renal cell carcinoma. J. Urol. 163, 408-417. <https://doi.org/10.1016/S0022-5347(05)67889-5>
24. Pizzocaro, G., Piva, L., Colavita, M., Ferri, S., Artusi, R., Boracchi, P., Parmiani, G., Marubini, E. (2001) Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma: a multicentric randomized study. J. Clin. Oncol. 19, 425-431. <https://doi.org/10.1200/JCO.2001.19.2.425>
25. Pomer, S., Thiele, R., Staehler, G., Drehmer, L., Lohrke, H., Schirrmacher, V. (1995) Tumor vaccination in renal cell carcinoma with and without interleukin-2 (IL-2) as adjuvant. A clinical contribution to the development of effective active specific immunization. Urologe A 34, 215-220.
26. Rabinovitch, R. A., Zelefsky, M. J., Gaynor, J. J., Fuks, Z. (1994) Patterns of failure following surgical resection of renal cell carcinoma: implications for adjunct local and systemic therapy. J. Clin. Oncol. 12, 206-212. <https://doi.org/10.1200/JCO.1994.12.1.206>
27. Rammensee, H. G. (1995) Chemistry of peptides associated with MHC class I and class II molecules. Curr. Opin. Immunol. 7, 85-96. <https://doi.org/10.1016/0952-7915(95)80033-6>
28. Repmann, R., Wagner, S., Richter, A. (1997) Adjuvant therapy of renal cell carcinoma with active-specificimmunotherapy (ASI) using autologous tumor vaccine. Anticancer Res. 17, 2879-2882.
29. Robson, C. J., Churchill, B. M., Anderson, W. (1969) The results of radical nephrectomy for renal cell carcinoma. J. Urol. 101, 297-301. <https://doi.org/10.1016/S0022-5347(17)62331-0>
30. Sandock, D. S., Seftel, A. D., Resnick, M. I. (1995) A new protocol for the followup of renal cell carcinoma based on pathological stage. J. Urol. 154, 28-31. <https://doi.org/10.1016/S0022-5347(01)67215-X>
31. Stevanovic, S., Pomer, S., Rammensee, H. G. (1995) Surface antigens in renal cell carcinoma: presentation of MHC Irestricted self peptides. Akt. Urol. 26, 45-46. <https://doi.org/10.1055/s-2008-1057856>
32. Störkel, S., Thoenes, W., Jacobi, G. H., Lippold, R. (1989) Prognostic parameters in renal cell carcinoma - a new approach. Eur. Urol. 16, 416-422. <https://doi.org/10.1159/000471633>
33. Tsui, K. H., Shvarts, O., Smith, R. B., Figlin, R. A., deKernion, J. B., Belldegrun, A. (2000) Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J. Urol. 163, 1090-1095. <https://doi.org/10.1016/S0022-5347(05)67699-9>
34. Wittekind, C., Wagner, G. (1997) TNM Classification of malignant tumors. 5th edition, Springer, Berlin/Heidelberg. http://www.seer.cancer.gov
35. Yagoda, A., Bassam, A. R., Petrylak, D. (1995) Chemotherapy for advanced renal cell carcinoma 1983-1993. Semin. Oncol. 22, 42-60.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive